Fewer Than Half Of Children On Medicaid Receive Life-Saving Sickle-Cell Screenings, CDC Says
Executive Summary
A CDC study found that fewer than half of children with sickle cell disease were getting screened for strokes, and fewer than 40% of children were taking recommended medications.
You may also be interested in...
Start-Up Spotlight: NovaSignal Aims To Commercialize Transcranial Ultrasound
With a mostly forgotten imaging modality, NovaSignal is trying to create the “fifth vital sign.” Medtech Insight spoke to chairman and chief executive officer, Diane Bryant, to learn more about the company's transcranial ultrasound technology.
Stroke Devices: Hope Amid Headwinds
Despite market headwinds, the endovascular treatment of acute ischemic stroke remains a growing and highly under-penetrated market opportunity valued at more than $1 billion worldwide. Although advances in neurothrombectomy devices, access catheters, imaging, and neuroprotective therapies have the potential to help expand the treatable population, positive Level I clinical evidence is needed to drive adoption and market growth.
FDA's Updated Draft Animal Testing Guidance Clarifies Its Scope
The US FDA’s guidance document on animal testing for medical devices clarifies the scope of a document issued in 2016.